Precision BioSciences (NASDAQ: DTIL) reported Q3 EPS of ($0.07), $0.12 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $13.12 million versus the consensus estimate of $8.6 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.